🇺🇸 FDA
Pipeline program

Cognitive behavioral therapy for anxiety plus benzodiazepine taper

IRB#22-001451

Unknown other completed

Quick answer

Cognitive behavioral therapy for anxiety plus benzodiazepine taper for Anxiety Disorders is a Unknown program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Anxiety Disorders
Phase
Unknown
Modality
other
Status
completed

Clinical trials